Sangamo Therapeutics
SGMO
#9910
Rank
$70.42 M
Marketcap
$0.17
Share price
0.00%
Change (1 day)
-60.47%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : $29.61 Million USD

According to Sangamo Therapeutics 's latest financial reports the company has $29.61 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$41.91 M-48.25%
2023-12-31$81 M-70.82%
2022-12-31$0.27 B-26.27%
2021-12-31$0.37 B-41.29%
2020-12-31$0.64 B76.96%
2019-12-31$0.36 B-9.41%
2018-12-31$0.40 B64.46%
2017-12-31$0.24 B70.7%
2016-12-31$0.14 B-31.8%
2015-12-31$0.20 B16.78%
2014-12-31$0.17 B92.82%
2013-12-31$92.81 M46.05%
2012-12-31$63.54 M-24.47%
2011-12-31$84.13 M39.56%
2010-12-31$60.28 M-29.03%
2009-12-31$84.94 M31.02%
2008-12-31$64.83 M-20.05%
2007-12-31$81.08 M50.39%
2006-12-31$53.92 M14.83%
2005-12-31$46.95 M41.18%
2004-12-31$33.26 M-24.16%
2003-12-31$43.85 M-15.89%
2002-12-31$52.14 M-15.34%
2001-12-31$61.59 M-3.02%
2000-12-31$63.51 M735.66%
1999-12-31$7.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$22.05 B 74,356.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$12.03 B 40,546.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$4.28 B 14,360.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
$3.85 B 12,903.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$7.64 B 25,707.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$5.70 B 19,153.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$3.00 B 10,060.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.22 B 7,404.19%๐Ÿ‡บ๐Ÿ‡ธ USA